3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
76
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Burkitt Lymphoma
16
Recurrence
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Neoplasms, Plasma Cell
5
Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Immunoglobulin Light-chain Amyloidosis
5
Smoldering Multiple Myeloma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Leukemia
4
Neoplasm Metastasis
3
Down Syndrome
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Waldenstrom Macroglobulinemia
2
Prostatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma, B-Cell
2
Lung Neoplasms
2
Leukemia, Hairy Cell
2
Hodgkin Disease
2
Fatigue
2
Brain Neoplasms
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Interventions
Gemcitabine
56
pembrolizumab
50
Cisplatin
43
Magnetic Resonance Spectroscopy
27
enfortumab vedotin
22
Specimen Handling
22
Nivolumab
22
Cystectomy
18
durvalumab
16
Carboplatin
16
avelumab
15
Mitomycin
14
atezolizumab
13
Docetaxel
13
Cystoscopy
12
Fluorouracil
11
Radiation
9
Transurethral Resection of Bladder
8
Radiotherapy
8
Ipilimumab
8
sacituzumab govitecan
7
Standard of Care
7
Radiosurgery
7
Paclitaxel
7
Immunoglobulin G
7
Disulfides
7
erdafitinib
6
cemiplimab
6
Surveys and Questionnaires
6
Surgical Procedures, Operative
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Calcium Dobesilate
×
1 year
×
Clear all
No trials found.